Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001104659-20-073505
Filing Date
2020-06-15
Accepted
2020-06-15 20:26:29
Documents
3
Effectiveness Date
2020-06-15

Document Format Files

Seq Description Document Type Size
1 S-3MEF tm2022604-5_s3mef.htm S-3MEF 39009
2 EXHIBIT 5.1 tm2022604d5_ex5-1.htm EX-5.1 8860
3 EXHIBIT 23.1 tm2022604d5_ex23-1.htm EX-23.1 1926
  Complete submission text file 0001104659-20-073505.txt   51047
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-239199 | Film No.: 20964703
SIC: 2835 In Vitro & In Vivo Diagnostic Substances